Commonwealth Equity Services’s Franklin Genomic Advancements ETF HELX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $212K | Sell |
|
|||||
|
2024
Q1 | $231K | Hold |
|
|||||
|
2023
Q4 | $215K | Sell |
|
|||||
|
2023
Q3 | $225K | Buy |
|
|||||
|
2023
Q2 | $239K | Sell |
|
|||||
|
2023
Q1 | $264 | Sell |
|
|||||
|
2022
Q4 | $272K | Buy |
|
|||||
|
2022
Q3 | $262K | Buy |
|
|||||
|
2022
Q2 | $271K | Sell |
|
|||||
|
2022
Q1 | $392K | Sell |
|
|||||
|
2021
Q4 | $727K | Sell |
|
|||||
|
2021
Q3 | $791K | Sell |
|
|||||
|
2021
Q2 | $845K | Sell |
|
|||||
|
2021
Q1 | $710K | Buy |
|
|||||
|
2020
Q4 | $270K | Buy |
|
|||||
|
2020
Q3 | $207K | Buy |
|